首页
>
期刊首页
>
中草药(英文版)
>
2026年3期
>
From empiricism to precision:SHINE strategy in anti-fibrotic drug discovery
From empiricism to precision:SHINE strategy in anti-fibrotic drug discovery
摘要
Fibrosis contributes substantially to global morbidity and mor-tality,while approved agents such as pirfenidone and nintedanib(Table 1)primarily delay disease progression rather than reverse established scarring(King et al.,2014).This persistent therapeutic gap has renewed interest in alternative sources of anti-fibrotic leads.Traditional Chinese medicine(TCM)formulas represent a vast and clinically validated repository of multi-component ther-apies,yet conventional reductionist drug discovery paradigms have struggled to fully harness their complexity.In this context,Xin et al.propose the smart herbal-based innovation and transla-tional engine(SHINE),an integrative framework that bridges TCM theory with artificial intelligence(AI),multi-omics technologies,and biosynthetic engineering to accelerate anti-fibrotic drug dis-covery(Xin et al.,2025).The SHINE framework specifically oper-ationalizes this integration through tissue-directed intelligent screening,physiologically based pharmacokinetic(PBPK)model-ing,and spatial metabolomics,thereby translating the TCM con-cept of"meridian tropism"into quantifiable distribution parameters.
年,卷(期):
2026, 18(3)
机标分类号:
TN722.75
TP311.5
F425
在线出版日期:
2026年8月26日